PARACETAMOL , -, -, CARBOPLATIN , -, MK-2870, PEMETREXED
MK-2870-009
Phase 3 small_molecule active
Quick answer
PARACETAMOL , -, -, CARBOPLATIN , -, MK-2870, PEMETREXED for Non-small Cell Lung Cancer (NSCLC) is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Non-small Cell Lung Cancer (NSCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active